Reviews
Recommend
Trust
Listening
Dr Dionysis Papadatos-Pastos
2024-06-03
Person
5
5
0
3rd June 2024
Dr Papadatos-Pastos is very approachable and reassuring and always makes me feel comfortable and explains everything in depth. I feel I am receiving the best treatment and care having him as my oncologist. Always professional and caring towards me and my family.
Dr Dionysis Papadatos-Pastos
2024-05-31
Person
5
5
0
31st May 2024
Dr Papadatos-Pastos has an approachable, reassuring, demeanour. He reacts/responds to my queries or concerns in a clear, succinct, efficient manner..
I’m totally comfortable to remain under Dr Papadatos-Pastos’ care to discuss my 6 monthly updates, following a lung lobectomy procedure @ UCLH
Dr Dionysis Papadatos-Pastos
2024-05-29
Person
5
5
0
29th May 2024
I have been attending hospital for nearly 5 years and in all honesty I have been extremely well looked after by my oncologist Dr Papadatos-Patos and his team, any queries are delt with straight away.
Dr Dionysis Papadatos-Pastos
2024-05-29
Person
4
5
0
29th May 2024
Manner is friendly and reassuring. Good at listening to patient and addressing their concerns. Demonstrates sound medical knowledge and explains things well so that you trust their judgment.
Specialises in
- Oncology
Profile
Dr Dionysis Papadatos-Pastos is a consultant medical oncologist in London. He is the lead for lung cancer in the CRUK UCL Clinical Trials Centre and the joint lead for oncology at The Princess Alexandra NHS Hospital.
He specialises in the treatment of lung cancer, mesothelioma, and thymoma. Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies, and chemotherapy.
He graduated in medicine from the University of Athens with distinction, which was followed by his PhD in medical oncology in 2012 with First Class honours. He trained in medical oncology at The Royal Marsden, St George’s University Hospitals, and Guy’s and St Thomas’. He was awarded a diploma in medical oncology from the Institute of Cancer Research at the University of London.
Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has also presented at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.